MEDANTAstockGlobal Health Ltd
₹1,254.6
▲+1.55%
Open
₹1,237.6
High
₹1,270.35
Low
₹1,237
Volume
370.7K
Price chart
Daily close · downsampled 5-year history
2022-11-16 · ₹415.652026-06-18 · ₹1,265.85
Instrument details
- MB Code
- MBEQU2290
- Type
- stock
- ISIN
- INE474Q01031
- BSE
- 543654
- Industry
- Healthcare Services
Latest earnings
Q4FY26 declared
- Quarter
- Mar 2026
- Revenue
- 1159.05 Cr
- Net profit
- 141.65 Cr
- EPS
- 5.35
- YoY revenue
- +24.46%
Price returns
Historical performance
- 1 day
- +0.90%
- 1 month
- +2.44%
- 3 months
- +25.96%
- 1 year
- +8.02%
- 3 years
- +98.46%
- 5 years
- +204.55%
Technicals
Indicator consensus
Bullish
35
Neutral
5
Bearish
6
RSI 69.36(Neutral)
Company documents
Annual reports, concalls, presentations
Concall transcripts
26Investor presentations
30Corporate announcements
461Corporate timeline
Price chart events · 1 year
Dividend
2025-08-22
{"amount":0.5}
Earnings
2026-05-14
{"actualRevenue":11590470000,"estimateRevenue":11295000000,"revenueSurprise":295470000,"revenueSurprisePercent":2.61593625498008,"actualEPS":5.35,"estimateEPS":4.386,"surprise":0.9639999999999995,"surprisePercent":21.97902416780665}
Earnings
2026-02-04
{"actualRevenue":11210470000,"estimateRevenue":10955000000,"revenueSurprise":255470000,"revenueSurprisePercent":2.331994523048836,"actualEPS":4.9,"estimateEPS":4.896,"surprise":0.004000000000000448,"surprisePercent":0.0816993464052379}
Earnings
2025-11-07
{"actualRevenue":10992220000,"estimateRevenue":11058000000,"revenueSurprise":-65780000,"revenueSurprisePercent":-0.5948634472779888,"actualEPS":5.296,"estimateEPS":6.12,"surprise":-0.8239999999999998,"surprisePercent":-13.4640522875817}
Earnings
2025-08-07
{"actualRevenue":10308370000,"estimateRevenue":9881000000,"revenueSurprise":427370000,"revenueSurprisePercent":4.325169517255339,"actualEPS":5.18,"estimateEPS":5.355,"surprise":-0.1750000000000007,"surprisePercent":-3.267973856209163}
News
2026-05-14
{"description":"Global Health Q4 net profit rose 41.9% to ₹143.9 crore and revenue 24.5% to ₹1,159 crore, but EBITDA margin fell to 21%; board recommended ₹0.50 final dividend and approved FY26 results.","url":"https://www.cnbctv18.com/market/earnings/global-health-q4-profit-jumps-41-9pc-to-rs143-9-cr-revenue-rises-24-5-margins-decline-ws-l-19906066.htm","sentiment":"Positive","domain":"CNBCTV18"}
News
2025-07-02
{"description":"Nifty-50 is anticipated to find short-term support at 25,450, with resistance at 25,670. Key global market trends will influence trading strategies for today, 2 July 2025, along with recommendations for eight stocks to buy or sell.","url":"https://www.msn.com/en-in/money/top-stocks/stock-market-today-trade-setup-for-nifty-50-to-global-markets-eight-stocks-to-buy-or-sell-wednesday-2-july-2025/ar-AA1HNi0c?ocid=BingNewsVerp","sentiment":"Neutral","domain":"Mint on MSN"}